Improvement of endothelium-dependent vasodilation in old mice by GDF11
LIU Ting1, ZHANG Chengying2, SU Jingke2, HAN Ning2, and ZHU Biao3
1.Department of Electrocardiogram, Beijing Nuclear Industry Hospital, Beijing, 102413,China; 2. Department of Nephrology, General Hospital of Chinese People’s Armed Police Force, Beijing 100039,China; 3. Department of Stomatology, Affiliated Hospital of Hebei University, Baoding 071000,China
Abstract： Objective To investigate the effects of GDF11 on endothelium-dependent vasodilation of the aorta in old mice.Methods Twenty 18-month-old C57 mice were randomly divided into GDF11 group [0.3 mg/(kg·d)] recombinant GDF11 intraperitoneal injection, n=10) and Vehi group (equivalent physiological saline injection, n=10). After four weeks of intervention, blood biomarkers of lipid metabolism were tested, while relaxation response and Western blot were determined in the isolated aorta.Results GDF11 intervention significantly increased endothelium-dependent vasodilation in response to acetylcholine (Ach) [10-6 mol/L Ach: (37.1±5.2)% vs (59.7±4.3)%、10-5 mol/L Ach: (48.2±4.0)% vs (78.4±5.6)%、10-4 mol/L Ach: (61.1±4.7)% vs (90.2±7.4)%], decreased triglyceride levels in serum [(76.6±11.2) vs (64.5±10.4) mg/dl], elevated adiponectin protein levels [(11.9±1.1) vs (14.2±1.7) μg/ml] and enhanced protein levels of phosphorylated Samd2/3 [p-Smad2: (1.00±0.05) vs (1.78±0.10)]、p-Smad3 [(1.00±0.09) vs (1.57±0.12)].Conclusions GDF11 can attenuate impaired endothelium-dependent vasodilation in old mice.
刘婷,张承英,苏静克,韩宁,朱彪. GDF 11改善老龄鼠内皮依赖性血管舒张功能的实验研究[J]. 武警医学, 2018, 29(7): 702-701.
LIU Ting, ZHANG Chengying, SU Jingke, HAN Ning, and ZHU Biao. Improvement of endothelium-dependent vasodilation in old mice by GDF11. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(7): 702-701.
Verma S, Buchanan M R, Anderson T J. Endothelial function testing as a biomarker of vascular disease[J]. Circulation, 2003,108(17):2054-2059.
[2]
Lu J, Xiang G, Liu M, et al. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice[J]. Atherosclerosis, 2015,243(2):438-448.
[3]
Benjamin E J, Blaha M J, Chiuve S E, et al. Heart disease and stroke statistics-2017 update: a report From the American Heart Association[J]. Circulation, 2017,135(10):e146-e603.
[4]
Li H, Li Y, Xiang L, et al. GDF11 Attenuates development of type 2 diabetes via improvement of islet beta-cell function and survival[J]. Diabetes, 2017,66(7):1914-1927.
[5]
Katsimpardi L, Litterman N K, Schein P A, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014,344(6184):630-634.
Mei W, Xiang G, Li Y, et al. GDF11 protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein e-null mice[J]. Mol Ther, 2016,24(11):1926-1938.
[8]
Hou N, Du G, Han F, et al. Irisin regulates heme oxygenase-1/adiponectin axis in perivascular adipose tissue and improves endothelial dysfunction in diet-induced obese mice[J]. Cell Physiol Biochem, 2017,42(2):603-614.
Withers S B, Simpson L, Fattah S, et al. cGMP-dependent protein kinase (PKG) mediates the anticontractile capacity of perivascular adipose tissue[J]. Cardiovasc Res, 2014,101(1):130-137.
[11]
Liu Y, Retnakaran R, Hanley A, et al. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects[J]. J Clin Endocrinol Metab, 2007,92(11):4313-4318.
2018, Vol. 29 
